About the Journal
Cancer poses a major challenge to development; it undermines socio-economic advances throughout the world. It is estimated that the number of patients with cancer would increase from 12.7 million in the year 2008 to 22.2 million by 2030. It is universally agreed that the condition is reaching epidemic proportions. At this time, the European Journal of Clinical Oncology is conveniently placed in the scholarly communication milieu to help counter the menace of cancer by aiding the development of novel treatment strategies, by providing novel insights into the mechanisms underlying this complex disease. It is a well-known fact that, advances in care are enabling cancer patients to live longer, and lead better quality lives. With the enhancements in the knowledge of the aetiology of cancer, survival has improved substantially. In this setting, the European Journal of Clinical Oncology provides a high-profile platform to showcase major advances in cancer research.
Scope of the Journal
European Journal of Clinical Oncology strives to publish highest quality articles pertaining to clinical research, which are freely accessible to one and all. The scope of the journal encompasses topics Cancer Biology, prostate cancer, colorectal cancer, cancer immuno therapy, chemotherapy, cancer radiology, therapeutic cancer, cancer pathology.
Though original reports remain the primary focus of the journal, but this format of scientific communication is reinforced by appropriately selected commentaries, reviews, editorials, and other clinical work that relates to the care of cancer patients.
In order to create highly impactful and original content, the European Journal of Clinical Oncology has gathered an expert Editorial Board, comprising of illustrious scientists who ensure that each manuscript is fairly, but stringently peer-reviewed.
The team at the European Journal of Clinical Oncology takes immense pride in providing the authors with a streamlined and courteous publishing experience.